Category:
Active Pharmaceutical Ingredients
CAS NO:
1025967-78-5
Standard:
In-house Standards,
Rare Disease Dry Eye Disease
Lifitegrast is an integrin antagonist developed for ophthalmic therapy, specifically targeting the lymphocyte function-associated antigen-1 (LFA-1) pathway. Its core synthesis involves complex chiral resolution and peptide coupling strategies to ensure high optical purity. The molecular formula is C24H36N8O5S2 with CAS registry number 1019537-46-2.
Strictly limited to prescription use under medical supervision. Avoid contact with eyes prior to administration if not formulated correctly. Store API in a cool, dry place below 25°C protected from light to maintain chemical stability.